Weight loss jabs should be probed as potential " cancer prevention agents", experts say. A study has shown weight loss injections used to tackle obesity and type 2 diabetes - including Mounjaro, Wegovy and Ozempiccan - may have wider health benefits. Experts from the US examined data on more than 161,000 patients who were obese, did not have diabetes and had not been diagnosed with an obesity-related cancer. Of these, half used weight-loss injections while the other half were given consultation